| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | BIO | Jun 30, 2026 | |
| Sell | Bio | Apr 8, 2026 | |
| Sell | Bio | Mar 26, 2026 | |
| Sell | Bio | Feb 24, 2026 | |
| Sell | Bio | Jan 28, 2026 | |
| Buy | Bio | Dec 5, 2025 | |
| Buy | Bio | Dec 2, 2025 | |
| Buy | Bio | Oct 22, 2025 | |
| Sell | Bio | Aug 1, 2025 | |
| Buy | BIO | May 28, 2025 |
This page tracks congressional stock trading activity in Bio-Techne Corporation (TECH) in the Healthcare sector. Disclosed Capitol has indexed 63 disclosed congressional trades involving TECH. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of July 2026 — Disclosed Capitol has tracked 63 disclosed congressional trades in Bio-Techne Corporation (TECH) — 30:20 buy-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Jun 30, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Apr 8, 2026 | April McClain Delaney | D | Sell | $1,001 - $15,000 |
| Mar 26, 2026 | April McClain Delaney | D | Sell | $1,001 - $15,000 |
| Feb 24, 2026 | April McClain Delaney | D | Sell | $1,001 - $15,000 |
| Jan 28, 2026 | April McClain Delaney | D | Sale | $1,001 - $15,000 |
| Dec 5, 2025 | April McClain Delaney | D | Buy | $1,001 - $15,000 |
| Dec 2, 2025 | April McClain Delaney | D | Buy | $1,001 - $15,000 |
| Oct 22, 2025 | April McClain Delaney | D | Buy | $1,001 - $15,000 |
| Aug 1, 2025 | April McClain Delaney | D | Sale | $1,001 - $15,000 |
| May 28, 2025 | Ro Khanna | D | Purchase | $50,001 - $100,000 |
Across the 63 disclosed congressional trades in Bio-Techne Corporation (TECH), members of Congress have reported 30 buys and 20 sells. The average 30-day alpha vs. the S&P 500 is -1.23%.
For fiscal year 2026, Bio-Techne Corporation reported revenue of $1.22B and net income of $73.4M, per SEC filings.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.